Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Oberarzt/-ärztin, Klinik für Neurologie
Aktuelle Veranstaltungen
-
SoSe 2026
Vergangene Veranstaltungen (max. 10)
-
WiSe 2025
-
SoSe 2025
-
WiSe 2024
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Correction: Matched-pair analysis of motor outcomes in adults with spinal muscular atrophy on nusinersen vs. risdiplam (Journal of Neurology, (2026), 273, 1, (55), 10.1007/s00415-025-13589-w)In: Journal of Neurology, Jg. 273, 2026, Nr. 4, 236DOI (Open Access)
-
Apheresis therapies in MOGAD : A retrospective study of 117 therapeutic interventions in 571 attacksIn: Journal of Neurology, Neurosurgery and Psychiatry, Jg. 96, 2025, Nr. 7, S. 639 – 646DOI (Open Access)
-
Association of body mass index and clinical response in patients receiving ofatumumab for treatment of multiple sclerosisIn: Journal of Neurology, Neurosurgery and Psychiatry, Jg. 96, 2025, Nr. 8, S. 802 – 806DOI (Open Access)
-
Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or OfatumumabIn: Annals of Neurology, Jg. 97, 2025, Nr. 3, S. 583 – 595DOI (Open Access)
-
Disease-modifying strategies : Targeting protein kinases in multiple sclerosis and other autoimmune disordersIn: Autoimmunity Reviews, Jg. 24, 2025, Nr. 4, 103754DOI (Open Access)
-
First insights into the safety and effectiveness of additional courses with cladribine tablets under real-world conditionsIn: Multiple Sclerosis and Related Disorders, Jg. 97, 2025, 106398DOI (Open Access)
-
Glatiramer Acetate Modifies the Immune Profiles of Monocyte-Derived Dendritic Cells In Vitro Without Affecting Their GenerationIn: International Journal of Molecular Sciences (IJMS), Jg. 26, 2025, Nr. 7, 3013DOI (Open Access)
-
Is therapy-free remission a realistic goal with cladribine tablets in multiple sclerosis? : New insights into the mechanism of action and clinical implications of immune reconstitution with cladribine tablets in MS therapyIn: Journal of Neurology, Jg. 272, 2025, Nr. 12, 788DOI (Open Access)
-
Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumabIn: Neurological Research and Practice, Jg. 7, 2025, Nr. 1, 58DOI (Open Access)
-
Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritisIn: Neurological Research and Practice, Jg. 7, 2025, Nr. 1, 48DOI (Open Access)
-
Safety and Efficacy of Cladribine in Patients Discontinuing Fingolimod Due to Elevated Transaminase Levels : The FinClad StudyIn: Multiple Sclerosis and Related Disorders, Jg. 101, 2025, 106578
-
The impact of autoimmune comorbidities on multiple sclerosis progression: : insights from a longitudinal single-center studyIn: Journal of Neurology, Jg. 272, 2025, Nr. 9, S. 607DOI (Open Access)
-
Association of Clinical Relapses With Disease Outcomes in Multiple Sclerosis Patients Older Than 50 YearsIn: Neurology, Jg. 103, 2024, Nr. 2, e209574DOI, Online Volltext (Open Access)
-
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease : A prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)In: Journal of Neurology, Neurosurgery and Psychiatry, Jg. 96, 2024, Nr. 3, S. 296 – 305DOI (Open Access)
-
Cognitive Impairment, Associated Clinical Factors, and MR Volumetric Measures in Myelin Oligodendrocyte Glycoprotein-IgG-Associated DiseaseIn: Neurology: Neuroimmunology & Neuroinflammation, Jg. 11, 2024, Nr. 6, e200325DOI (Open Access)
-
Eculizumab Use in Neuromyelitis Optica Spectrum DisordersIn: Neurology, Jg. 103, 2024, Nr. 9, e209888DOI (Open Access)
-
Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patientsIn: Neurological Research and Practice, Jg. 6, 2024, Nr. 1, 55DOI (Open Access)
-
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGADIn: Journal of Neurology, Neurosurgery and Psychiatry, Jg. 96, 2024, Nr. 6, S. 582 – 592DOI (Open Access)
-
Real-world therapy management of patients with multiple sclerosis receiving cladribine tablets beyond year 4 : Results from a German cladribine cohortIn: Multiple Sclerosis and Related Disorders, Jg. 88, 2024, 105704DOI (Open Access)
-
Reorganization of the actin cytoskeleton during the formation of neutrophil extracellular traps (NETs)In: European Journal of Cell Biology (EJCB), Jg. 103, 2024, Nr. 2, 151407DOI (Open Access)
-
Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany : Baseline characteristics of the POWER@MS1 randomised controlled trialIn: Multiple Sclerosis and Related Disorders, Jg. 79, 2023, 105043DOI (Open Access)
-
MOG antibody–associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination : A case reportIn: Therapeutic Advances in Neurological Disorders, Jg. 15, 2022DOI (Open Access)
-
Case Report : Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant MelanomaIn: Frontiers in Oncology, Jg. 11, 2021, S. 637185DOI, Online Volltext (Open Access)
-
A fatal case of daclizumab-induced liver failure in a patient with MSIn: Neurology: Neuroimmunology & Neuroinflammation, Jg. 6, 2019, Nr. 2, e539DOI (Open Access)
-
Apheresis in MOGAD : retrospective data of 117 therapeutic interventions from the German Neuromyelitis Optica Study Group (NEMOS)In: Multiple Sclerosis Journal. London: Sage, Jg. 30, 2024, Nr. Suppl. 3, S. 410 – 412
-
Development of serum immunoglobulin levels following treatment with ocrelizumab or ofatumumab for active RMSIn: Multiple Sclerosis Journal. London: Sage, Jg. 30, 2024, Nr. Suppl. 3, S. 361 – 362(Open Access)
-
Eculizumab use in neuromyelitis optica spectrum disorders : routine clinical care data from a European cohortIn: Multiple Sclerosis Journal. London: Sage, Jg. 30, 2024, Nr. Suppl. 3, S. 649 – 651
-
Prevalence and impact of migraine in multiple sclerosis : a cross-sectional observational single-centre studyIn: Multiple Sclerosis Journal. London: Sage, Jg. 30, 2024, Nr. Suppl. 3, S. 477 – 478
-
Retrospective data analysis of a German cohort of patients with active relapsing multiple sclerosis switching from anti-CD20 therapies to cladribine tablets and vice versaIn: Multiple Sclerosis Journal. London: Sage, Jg. 30, 2024, Nr. Suppl. 3, S. 328 – 330